Skip Navigation

Link to  the National Institutes of Health NIDA NEWS NIDA News RSS Feed
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Keep Your Body Healthy
Go to the Home pageGo to the About Nida pageGo to the News pageGo to the Meetings & Events pageGo to the Funding pageGo to the Publications page
PhysiciansResearchersParents/TeachersStudents/Young AdultsEn Español Drugs of Abuse & Related Topics

NIDA Home > What's New > Past Meetings Summaries    

PROCEEDINGS OF A CONFERENCE:
Blood-Borne and Sexually Transmitted Infections Among IDUs and Their Partners in the Western Hemisphere: Exchange of Experiences and Lessons Learned
REGIONAL EXPERT CONSULTATION



[Introduction] [Agenda] [Abstracts] [Recommendations] [Biographical Sketches] [Participants]

Agenda

Monday, December 17, 2001

9:00-10:00 Opening Ceremony  
  9:00-9:10 Dr. Juan Manuel Sotelo
PAHO/WHO Representative in Argentina
  9:10-9:20 Dr. Lorenzo Cortese
Secretary of Programming for the Prevention of Drug Addiction and Fight against Drug Trafficking of the Nation's Presidency
  9:20-9:30 Dr. Henry Francis
Director HIV Program, NIDA
  9:30-9:40 Dr. Pedro Chequer
Inter-country Program Advisor. UNAIDS
  9:40-9:50 Dr. Fernando Zacarias
Program Coordinator, Regional HIV/AIDS/STI Program PAHO
10:00-10:15 Objectives and Expected Outcomes
Jag Khalsa (NIDA) / Rafael Mazin/Armando Peruga (PAHO)
 

Situation Analysis, Dimensions and Trends of the Problem
Moderators: Armando Peruga (PAHO)/Jerry Flanzer (NIDA)

10:15-11:15 Part I
Epidemiology of Drug Use and HIV (Industrialized and Developing Countries)
  • Situation in the United States, Jerry Flanzer (USA)
  • Epidemiology of HIV and other Blood-borne Pathogens among Injecting Drug Users Starting Detoxification in Metropolitan Barcelona, Robert Muga (Spain)
  • Situation in Latin America:
    • Franklin Alcaraz (Bolivia)
    • Sergio Sosa Estani (Argentina)
  • 11:15-11:30 Coffee Break
    11:30-12:30 Part II
    Political and Cultural Determinants for the Distribution of Blood-borne and Sexually Transmitted Infections among Specific Subpopulations
  • The Industrialized Countries Experience:
    • Mary Latka (USA)
    • Maria José Bravo (Spain)
  • The Developing Countries Experience:
    • Sylvia Inchaurraga (Argentina)
    • Carlos Magis (Mexico
  • 12:30-13:00 Discussion
    13:00-14:30 Lunch
     

    Obstacles for the Development of Prevention and Health Care Policies
    Moderators: Skip Francis (NIDA) / Fernando Zacarias (PAHO)

    14:30-16:00 What is Happening, What Needs to be Done, Who is Responsible, What Barriers Need to be Removed/Environment Changed
  • Patrica lnsúa (Spain)
  • Leonardo Costa, Raquel Magri (Uruguay)
  • Mariano Montenegro (CONACE, Chile)
  • Fabio Mesquita (Brazil/Brasil)
  • Graciela Touzé (Argentina)
  • Drug Treatment as HIV prevention, David Metzger (USA)
  • 16:00-16:30 Coffee Break
    16:30-17:30 Two Examples of "Best Practices" in Progress: Prevention of Sexual Transmission and MTCT Prevention
  • Argentine participant. Damian Lavarello
  • Discussant: Mary Latka (USA)
  •  

    Tuesday, December 18, 2001

     

    Obstacles for the Development of Prevention and Health Care Policies
    Moderators: Skip Francis (NIDA) / Fernando Zacarias (PAHO)

    9:00-10:30 Conditions

    Health Effects of Drug Abuse and Co-occurring Morbidity Conditions
  • HIV, HBV, HCV, Mercedes Weissenbacher (Argentina)
  • Improving Hepatitis B Virus Immunization Among Young Injectors in San Francisco, Paula Lum (USA)
  • Drug Abuse in HIV-lnfection: Risk of Neurological Disease and Treatment Issues, W. Royal (USA)
  • Health Care Access for IDU Infected with HIV, Steve Crystal (USA)
  • Tuberculosis in IDUs, Graciela Moscatello (Argentina)
  • The HIV Transmission Gradient: How Drug Injectors Protect Themselves and Their Partners, David Bell (USA)
  • 10:30-10:45 Coffee Break
    10:45-12:45 Cost-Effective Interventions documented
  • Is Lack of Adherence of IDUs a Groundless Assumption? Silvana De Castro (WHO), Fabio Mesquita-(Brazil)
  • Clinical Management of STI, and Hepatitis among IDUs, Graciela Moscatello (Argentina), Mônica Malta (Brazil)
  • HIV Risks and Patterns of Drug Treatment and Health Care among Puerto Rican Drug Users in Puerto Rico and New York, Rafaela Robles (USA)
  • Impact of Drug Treatment and Ambulatory Medical Care on HIV-infected Drug Users on Clinically Relevant Outcomes, Barbara Turner (USA)
  • Discussion: The Need for Comprehensive Care, including Prevention, Detoxification and Other Approaches.
    Discussants: Barbara Turner (USA) and Damian Lavarello (Argentina)
  • 12:45-14:15 Lunch
     

    Primary and Secondary Prevention Among IDUs and Their Sexual Partners: Success Stories
    Moderators: Skip Francis (NIDA) / Fernando Zacarias (PAHO)

    14:15-16:15
  • Sexual Interventions for Drug Abusers: What works? Mary Latka (USA)
  • Lessons Learned in Latin America: Diana Rossi (Argentina), Waleska Teixeira Caiaffa (Brazil)
  • Rapid Assessment on Intravenous Drug Use and Its Risk in Bogota, Ines Elvira Mejia (Colombia),
  • Special Challenges for the Implementation of Prevention Activities in Developing Countries, Graciela Radulich (Argentina), Maria Luz Osimani (Uruguay) and Fabio Mesquita (Brazil)
  • Discussion: Can Success Stories be adopted in different settings? Jag KhaIsa (NIDA)
  • 16:15-16:45 Coffee Break
    16:45-17:15 Report: MJ Bravo, R Mazin D Rossi, C Rius, M Weissenbacher

     

    Wednesday, December 19, 2001

     

    Technical Cooperation and Potential Areas of Collaboration
    Moderators: Henry Francis (NIDA) / Rafael Mazin (PAHO) / Jag Khalsa(NIDA)

    9:00-10:30 The "nuts and bolts" of technical cooperation among countries, organizations and groups
  • Dissemination of "Best Practices", Mercedes Weissenbacher, Rafael Mazin
  • NIDA's International Collaboration Agenda. Jag Khalsa
  • 10:30-11:00 Coffee Break
    11:00-12:45 Identification of Potential Areas of Collaboration Among Countries and Institutions (All participants)
    12:45-14:00 Lunch
    14:00-15:30 Questions and Answers about Specific Projects
    15:30-16:30 Recommendations, Suggestions for Follow-up and Closing Remarks

     

    Organizers

    Pan American Health Organization - World Health Organization
    Dr. Armando Peruga / Dr. Rafael Mazin / Dr. Fernando Zacarias

    National Institute on Drug Abuse - National Institutes of Health
    Dr. Jag Khalsa

    Spanish International Cooperation Agency
    Dr. Isabel Noguer

    Organizers in Argentina
    Dr. Mercedes Weissenbacher /Lic. Diana Rossi


    What's New Contents




    NIDA Home | Site Map | Search | FAQs | Accessibility | Privacy | FOIA (NIH) | Employment | Print Version



    National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Wednesday, February 2, 2005. The U.S. government's official web portal